What question did this study set out to answer?

This review aims to evaluate the clinical trials landscape for pulmonary sarcoidosis and propose future directions for treatment.

July 10, 2026Pulmonary TherapyOpen Access

Sarcoidosis: A Clinical Trials Perspective

View Full Paper

Ask AI

Bookmark

Authors

Review examines clinical trials for sarcoidosis treatments, highlighting the need for personalized medicine.

This review aims to evaluate the clinical trials landscape for pulmonary sarcoidosis and propose future directions for treatment.
Comprehensive review of recent clinical trials published over the past decade.
Emphasis on landmark studies that have influenced treatment practices.
Discussion of trial design limitations impacting outcomes.
Lower doses of prednisone showed similar effectiveness to higher doses for pulmonary sarcoidosis.
Methotrexate identified as a viable first-line alternative therapy.
Future trials should focus on personalized treatment with validated biomarkers and collaborative approaches.

Zapata-Huizi et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark